Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation (original) (raw)

• Gross TG, Egeler RM, Smith FO . Pediatric hematopoietic stem cell transplantation. Hematol Oncol Clin N Am 2001; 15: 795–808.
  Article CAS Google Scholar
• Marr KA, Carter RA, Crippa F et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant patients. Clin Infect Dis 2002; 34: 909–917.
  Article PubMed Google Scholar
• Van Burik JH, Weisdorf DJ . Infections in recipients of blood and marrow transplantation. Hematol Oncol Clin N Am 1999; 13: 1065–1089.
  Article CAS Google Scholar
• Brown JMY . Fungal infections in bone marrow transplant patients. Curr Opin Infect Dis 2004; 17: 347–352.
  Article PubMed Google Scholar
• Momin F, Chandrasekar PH . Antimicrobial prophylaxis in bone marrow transplantation. Ann Intern Med 1995; 123: 205–215.
  Article CAS PubMed Google Scholar
• Rolston K . Overview of systemic fungal infections. Oncology (Huntington) 2001; 15 (11 Suppl. 9): S11–S14.
  Google Scholar
• Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H . Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience for 10 years. Bone Marrow Transplant 2000; 26: 999–1004.
  Article CAS PubMed Google Scholar
• Busca A, Saroglia EM, Giacchino M et al. Analysis of early infectious complications in pediatric patients undergoing bone marrow transplantation. Support Care Cancer 1999; 7: 253–259.
  Article CAS PubMed PubMed Central Google Scholar
• Benjamin DKJ, Miller WC, Bavliff S et al. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002; 21: 227–234.
  Article PubMed Google Scholar
• Hoover M, Morgan ER, Kletzel M . Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. Med Pediatr Oncol 1997; 28: 268–273.
  Article CAS PubMed Google Scholar
• Martino R, Nomdedeu J, Altes A et al. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases. Bone Marrow Transplant 1994; 13: 265–269.
  CAS PubMed Google Scholar
• Richard C, Romon I, Baro J et al. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome. Bone Marrow Transplant 1993; 12: 237–241.
  CAS PubMed Google Scholar
• Fukuda T, Boeckh M, Guthrie KA et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant 2004; 10: 494–503.
  Article PubMed Google Scholar
• Bielorai B, Toren A, Wolach B et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant 2000; 26: 1025–1028.
  Article CAS PubMed Google Scholar
• Dallorso S, Manzitti C, Dodero P et al. Uneventful outcome of unrelated hematopoietic stem cell transplantation in a patient with leukemic transformation of Kostmann syndrome and long-lasting invasive pulmonary mycosis. Eur J Haematol 2003; 70: 322–325.
  Article PubMed Google Scholar
• Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.
  CAS PubMed Google Scholar
• Sullivan KM, Agura E, Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250–259.
  CAS PubMed Google Scholar
• Riley DK, Pavia AT, Beatty PG et al. The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med 1994; 97: 509–514.
  Article CAS PubMed Google Scholar
• Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
  Article CAS PubMed Google Scholar
• Dini G, Castagnola E, Comoli P et al. Infections after stem cell transplantation in children: state of the art and recommendations. Bone Marrow Transplant 2001; 28 (Suppl. 1): S18–S21.
  Article PubMed Google Scholar
• Fukada T, Boeckh M, Carter RA et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003; 102: 827–833.
  Article Google Scholar
• Busca A, Locatelli F, Barbui A et al. Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation. Transplant Infect Dis 2004; 5: 132–139.
  Article Google Scholar
• Wolff SN, Fay J, Stevens D et al. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. Bone Marrow Transplant 2000; 25: 853–859.
  Article CAS PubMed Google Scholar
• Baddley JW, Stroud TP, Salzman D, Pappas PG . Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001; 32: 1319–1324.
  Article CAS PubMed Google Scholar
• Benhamou E, Hartmann O, Nogues C et al. Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial. Bone Marrow Transplant 1991; 7: 127–131.
  CAS PubMed Google Scholar
• Klingspor L, Stintzing G, Fasth A, Tollemar J . Deep candidal infections in children receiving allogeneic bone marrow transplants: incidence, risk factors and diagnosis. Bone Marrow Transplant 1996; 17: 1043–1049.
  CAS PubMed Google Scholar
• Hoppe JE, Klausner M, Klingebiel T, Niethammer D . Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients. Mycoses 1997; 40: 47–54.
  Article CAS PubMed Google Scholar
• Sullivan KM, Dykewicz CA, Longworth DL et al. Preventing opportunistic infections after hematopoietic stem cell transplantation. American Society of Hematology Education Program Book. American Society of Hematology: Washington, DC, USA, 2003, pp 392–397.
  Google Scholar
• Wald A, Leisenring W, van Burik JA, Bowden RA . Epidemiology of Aspergillus infection in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459–1466.
  Article CAS PubMed Google Scholar
• Ayas M, Solh H, Mustafa MM et al. Bone marrow transplantation from matched siblings in patients with Fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant 2001; 27: 139–143.
  Article CAS PubMed Google Scholar
• Flowers ME, Doney KC, Storb R et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplant 1992; 9: 167–173.
  CAS PubMed Google Scholar
• Marr KA . Antifungal prophylaxis in hematopoietic stem cell transplant recipients. Oncology (Huntington) 2001; 15: 15–19.
  CAS Google Scholar
• Koh LP, Kurup A, Goh YT et al. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation. Am J Hematol 2002; 71: 260–267.
  Article CAS PubMed Google Scholar
• Stevens DA, Kan VL, Judson MA et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 696–709.
  Article CAS PubMed Google Scholar
• Avivi I, Oren I, Haddad N et al. Stem cell transplantation post invasive fungal infection is a feasible task. Am J Hematol 2004; 75: 6–11.
  Article PubMed Google Scholar